QQ客服 官方微博 反馈留言

	Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways
	Zhang Hai[1]; Li Jia-chuan[3]; Luo Han[4]; Zhao Lin[2]; Zhang Zhi-dan[5]; Shen Xiao-fei[2]
	2019
卷号	59
URL标识	查看原文
WOS记录号	WOS:000473048600004
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4339503
专题	成都中医药大学
作者单位	1.[1]Chengdu Univ Tradit Chinese Med, State Key Lab Breeding Base Systemat Res Dev & Ut, Sichuan Prov & Minist Sci & Technol, Chengdu, Sichuan, Peoples R China 2.[2]Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, West China Univ Hosp 2, Minist Educ, Chengdu, Sichuan, Peoples R China 3.[3]Southwest Minzu Univ, Sch Pharm, Chengdu, Sichuan, Peoples R China 4.[4]Sichuan Univ, West China Hosp, Dept Thyroid & Parathyroid Surg, Chengdu, Sichuan, Peoples R China 5.[5]Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China
推荐引用方式 GB/T 7714	Zhang Hai[1],Li Jia-chuan[3],Luo Han[4],et al. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways[J],2019,59.
APA	Zhang Hai[1],Li Jia-chuan[3],Luo Han[4],Zhao Lin[2],Zhang Zhi-dan[5],&Shen Xiao-fei[2].(2019).Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.,59.
MLA	Zhang Hai[1],et al."Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways".59(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。